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Background: The aim of this study was to conduct a cluster randomized control trial to assess the efficacy of
screening and brief intervention (SBI) for conjoint alcohol and tobacco use among hospital out-patients.
Method: In all 620 hospital out-patients who screened positive for both tobacco and alcohol moderate risk in four
hospitals were randomized into 2 control and 1 intervention condition using the hospital as a unit of randomization
(2 intervention and 2 control hospitals) to 405 patients in the two control groups (tobacco only intervention, n = 199,
and alcohol only intervention, n = 206) and 215 in the intervention group. The intervention or control consisted of
three counselling sessions.
Results: Results of the interaction (Group × Time) effects using GEE indicated that there were statistically significant
differences between the three study groups over the 6-month follow-up on the ASSIST tobacco score (Wald χ2 = 8.43,
P = 0.004), and past week tobacco use abstinence (Wald χ2 = 7.34, P = 0.007). Although there were no significant
interaction effects on the other outcomes (Alcohol ASSIST score, low alcohol risk score, past week tobacco abstinence
or low alcohol risk score, and past week tobacco abstinence and low alcohol risk score), the scores in all of the
six outcome measures showed consistent improvements. For past week tobacco abstinence the tobacco only
intervention was more effective than the alcohol only intervention and the integrated alcohol and tobacco intervention.
For the outcome of low alcohol risk, the alcohol only intervention and the integrated alcohol and tobacco intervention
was more effective than the tobacco only or alcohol only intervention.
Conclusions: The study found that for past week tobacco abstinence the tobacco only intervention was more effective
than the alcohol only intervention and the polydrug use (alcohol and tobacco) integrated intervention.
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In a national population survey in Thailand the prevalence
of joint (daily) smoking and harmful or hazardous alcohol
consumption in adults over 14 years of age was among
men 10.0 % [1], and in a large national study among high
school students, Saingam et al. [2] found 10 % of boys and
3 % of girls were co-users of alcohol and tobacco. In
different local studies in various health care settings in
Thailand a high prevalence of alcohol and/or tobacco
use was found, e.g., in primary care Southern Thailand
past 3 months tobacco use was among any past 3 months
substance user 91.3 % (of which 83.5 % were in the moder-
ate risk group) and alcohol use 33.5 % (of which 43.2 %
were in the moderate risk group) [3] and in general med-
ical clinics 60 % had used alcohol and 73.9 % had used to-
bacco in the past three months [4]. International studies
have shown that 20-30 % of patients who routinely present
in primary care are hazardous or harmful drinkers [5].
In the Thai national health examination population
survey the strongest predictor of harmful or hazardous
alcohol consumption in both sexes was currently smoking,
and likewise, the strongest predictor of current smoking
is harmful or hazardous alcohol use [1]. There is a high
association between nicotine and alcohol dependence [6].
Compared to one specific substance use dependence,
conjoint nicotine and alcohol dependence are more se-
vere and have a more unfavourable course [6]. Smoking
increases during alcohol consumption [7], and heavy
drinkers are less likely to attempt to quit smoking and
are less likely to be successful when they make an at-
tempt [8–10]. The integration of a brief intervention
for tobacco use and problem drinking is important be-
cause of (1) the prevalence of problem drinking is higher
among smokers than non-smokers [1, 11], (2) alcohol
consumption has been identified as a trigger for smoking
and for relapse to smoking among those who have already
quit, and heavy drinkers have significantly lower rates of
quitting smoking [11–13], and (3) the combined health
risks of smoking and problem drinking are higher than
the risks of smoking alone [11, 14]. Further, the existing
literature [11, 15–19] on the concurrent treatment of
smoking and drinking indicates that there may be some
benefit to combining services for these addictive behav-
iours. Given this demonstrated overlap in smoking and
drinking, the present study explores a brief intervention
for conjoint alcohol problem and tobacco users using
Kahler’s model [17].
To help reducing problems related to substance misuse,
the World Health Organization (WHO) recommends the
Alcohol, Smoking and Substance Involvement Screening
Test (ASSIST) [20] and its linked brief intervention (BI)
procedure to be used as an early intervention package
in primary health care (PHC) settings [21–24]. Several
meta-analyses have shown that screening using shortquestionnaires followed by brief intervention (comprising
simple advice or psychological counselling) significantly
reduces alcohol consumption in primary care popula-
tions [25–29]. Likewise, several meta-analyses found that
physician advice for smoking cessation [30], brief op-
portunistic smoking cessation interventions [31] and com-
bined pharmacotherapy and behavioural interventions for
smoking cessation [32] are effective to increase abstinence
in smoking. Further, the existing literature on the con-
current treatment of smoking and drinking indicates that
there may be some benefit to combining services for
these addictive behaviours [11, 15–19]. Compared with
most other BI studies (e.g., alcohol brief intervention in
Thailand: [33–38]), the present study combines two as-
pects that rarely are analyzed: a focus widened from a
single substance to a brief integrative multi-substance
(alcohol and tobacco) intervention and the efficacy of
the inclusion of booster sessions for poly drug use [39].
There is lack of information on the importance and ef-
fects of an integrative brief intervention (focusing on
both alcohol and tobacco use) of conjoint alcohol and
tobacco users using Kahler’s model [17], compared to the
single intervention of either smoking cessation or alcohol
risk reduction of conjoint alcohol and tobacco users.
The aim of this study is to conduct a cluster random-
ized control trial to assess the efficacy of SBI for conjoint
alcohol and tobacco use among hospital out-patients. Con-
senting patients screening positive for conjoint alcohol and
tobacco use risk are randomized, with the hospital clinic
being the unit of randomization into one of three arms:
The first arm being a three sessions Brief Intervention for
alcohol and tobacco arm (treatment arm) of conjoint alco-
hol and tobacco users using Kahler’s model [17], the
second arm being the smoking cessation only of conjoint
alcohol and tobacco users, and the third arm being the




The study setting is four district hospitals randomly
selected from 8 district hospitals in Nakhon Patthom
province in Thailand.
Design
In order to assess the efficacy of the Screening and Brief
Interventions (SBI) among participants found to be at mod-
erate risk for alcohol and tobacco use, a cluster randomized
controlled trial design was implemented. All out-patients
were screened using the ASSIST. Patients who met the cut-
off for moderate risk of conjoint alcohol and tobacco use,
both in the intervention and control arms, were reassessed
after baseline assessment at time 2 (3 months following
intervention) and time 3 (6 months following intervention).
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brief counselling about reducing alcohol use and smoking
cessation. The trial incorporated cluster randomization of
district hospitals to avoid the risk of contamination.
Study hypotheses
 Conjoint alcohol and tobacco users receiving the
integrative (both alcohol and tobacco) brief
intervention will experience a greater change in the
mean number of ASSIST alcohol use risk scores and
in the mean number of ASSIST tobacco use risk
scores, compared with the individuals receiving




Patients, age between 18 and 60 years; able to participate
in a 3- and 6-month follow-up post-intervention; able to
give contact details for at least two to three other people
(for purposes of follow-up); having a fixed address; not
pending incarceration within the next 3 months; absence
of cognitive impairment or severe behaviour problems;
not intoxicated or going through withdrawal from alcohol
or other drugs; and not currently in drug or alcohol or
nicotine treatment. Participants who scored between 0
and 26 on the ASSIST for cannabis, cocaine, ATS and
opioids, hallucinogens, sedatives, and inhalants, and par-
ticipants who score low between 0–3 for tobacco and
0–10 for alcohol were excluded from enrolment into
the study, but received information on drugs if relevant.
Participants who scored between 4 and 26 (moderate risk)
for tobacco and between 11–26 for alcohol (moderate
risk) were enrolled in the study and randomised to ei-
ther the Control or Intervention group. Participants who
scored in the high risk category (27 or higher for any of
the substances), or who had frequently injected drugs in
the last three months (more than 4 times per month on
average) were excluded from enrolment into the study
and were referred to specialist substance use treatment
services [37].
Randomisation
Randomisation was conducted using a secure remote
randomization service. The 4 out of 8 district hospitals
were randomly assigned to the treatment (co-joint inter-
vention) and control arms (alcohol only or tobacco only
interventions). Patients moderately at risk for conjoint
alcohol and tobacco use were randomized to either the
treatment or control groups. At clinic level all consecutive
patients were systematically recruited over a period of 3–4
months.Blinding
Participants (clinic staff members and patients) were
not blind to their intervention status. However, to
protect against information biases in the reporting of
substance use, the data collection team who assessed
the outcomes were blind to the hospital’s status as
intervention.Procedure
Universal screening of all patients was used whereby all
consecutive clients visiting the district hospital out-patient
department were screened for substance use problems and
in case of moderate conjoint alcohol and tobacco use risk
were offered a brief counselling intervention. A health care
provider informed the patient about the study and referred
the patient for participation if interested. A research as-
sistant (a professional researcher with a university degree,
employed by the research institution) asked for permission/
consent from patients attending the district hospital facility
to participate in the stage 1 of the study, i.e., screening or
baseline assessment using the ASSIST questionnaire. This
took about 5 min. The research assistant was not involved
in delivering the brief counselling intervention. All par-
ticipants underwent the initial assessment and the re-
search assistant scored the results of the ASSIST. Patients
who scored between 4 and 26 on the ASSIST (moderate-
risk range) for tobacco and scored between 11 and 26 on
the ASSIST (moderate-risk range) for alcohol were then
approached by the research assistant for a second in-
formed consent for enrolment in stage 2, the interven-
tion study. Patients scoring >26 on the ASSIST on any
of the substances (including tobacco and alcohol) were
referred for further management, and patients with to-
bacco use only scoring 0–26 and patients with alcohol
use only scoring 0–26 were provided with a health edu-
cation leaflet. For patients included in the study, the re-
search assistant referred the patient to a trained research
counsellor (the research counsellor has some professional
training in counselling, with a university degree in a health
related background) who carried out the intervention
(experimental or control) of three sessions within a period
of three weeks for all the participants after which
they were followed up in face-to-face interviews at
3 months and 6 months following the intervention at
the health facility, and assessments/interviews were
done by the research assistant. Participants received
in total 200 Baht transport reimbursement at 6-month
follow-up. We received ethical approval from the
Mahidol University Research and Ethics Committee
(COA. No. 2014/111.1804). The hospital management
of the study hospitals also provided approval for this
study. The study was conducted from May 2014 to
January 2015.
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Brief Counselling (integrative for both alcohol and tobacco
use) conjoint alcohol and tobacco users
The patients randomized and allocated to the intervention
arm completed baseline measures and received three ses-
sions of brief counselling for alcohol use reduction and to-
bacco use cessation intervention using the ASSIST-linked
brief intervention for hazardous and harmful substance
use manual for use in primary care [20, 21, 38]. In
addition, Kahler et al.'s brief intervention for heavy
drinking smokers was incooperated [17]: Feedback and
discussion on the relationship between drinking and
smoking, and on the potential effects of alcohol consump-
tion on smoking cessation; an emphasis on personal re-
sponsibility for choosing to change one's behaviour;
Advice to avoid or minimize drinking during the smok-
ing cessation process; a Menu of options for carrying out
a change strategy; use of Empathy by the clinician; and en-
couragement of Self-efficacy (i.e., confidence) for change.
Brief counselling (tobacco use only) conjoint alcohol and
tobacco users
The patients randomized and allocated to this control arm
received three sessions of brief counselling on tobacco use
cessation using the ASSIST-linked brief intervention for
hazardous and harmful substance use manual for use in
primary care [20, 21, 38].
Brief counselling (alcohol use only) conjoint alcohol and
tobacco users
The patients randomized and allocated to this control arm
received three sessions of brief counselling for alcohol use
reduction using the ASSIST-linked brief intervention for
hazardous and harmful substance use manual for use in
primary care [20, 21, 38].
Counsellor training
The intervention counsellors consisted of trained research
counsellors who delivered the interventions to patients as
per usual clinic services in a private consultation room.
All research counsellors who were suitable to deliver the
brief counselling intervention received formal training
(4 days) before data collection and supervision. The train-
ing took a practical, systems approach, aiming to facilitate
the implementation of SBI in clinic operations rather than
merely educating staff. The training curriculum contained
modules addressing practical issues deemed essential to
implementing the programme. For early identification of
substance use problems in primary care the ASSIST [4]
and for the brief intervention the WHO brief intervention
package for the ASSIST-linked brief intervention for
hazardous and harmful substance use were used [38].
In addition, Kahler et al.’s integrative module for alcohol
and tobacco use was used [17]. To help protect againstresearch counsellor drift, the brief intervention was com-
pletely manualized, including a Motivational Interviewing
(MI) protocol and used to guide the research counsellor
through the session content [40].
Intervention quality assurance
Assessment quality control was overseen by project staff,
and intervention fidelity was maintained by audio tape
recording of intervention sessions, interventionist check-
lists and reviewed by Apa Puckpinyo who provided feed-
back to research counsellors. Process evaluation included
a review of a random sample of 10 % of the assessments
and intervention audiotapes by the study coordinator for
fidelity to protocol. Supa Pengpid conducted quality as-
surance of 10 % of transcribed sessions and provided
feedback to Apa Puckpinyo for the research counsellors.
Monthly visits also included review, ongoing monitoring
and quality assurance. Evaluation also included review of




Baseline All patients (i.e., those in the treatment and
control arms) completed baseline measures which included
a Demographic Questionnaire, the ASSIST [36], the time-
line follow back (TLFB) interview (for alcohol and cigarette
use and past 7 days) [41–44] and health seeking behaviour
for substance use.
The primary outcome measure used in this study was
the change in the ASSIST alcohol use scores and ASSIST
tobacco use scores from baseline to follow-up. In addition,
we examine the point prevalence tobacco use outcomes
and drinking outcomes in terms of drinks per week from
the Timeline Followback (TLFB) interview.
Follow-up The same measures as detailed above were
administered (at follow-up) to the intervention and con-
trol groups of patients at 3 months and again at 6 months
following the intervention. To prevent lost to follow up,
and retain participants in the program; the regular com-
munication through series of communication via SMS
and Letter/ Postcards for reminding that they were in
the programme and was sent out at least 2 weeks prior
interviewing date.
Sample size calculation
The study assumes a 20 % reduction of the ASSIST score
from previous studies [38, 45]. The sample size calculated
by using PST Version 1.3, based on the average number of
40 patients per hospital per day, minimum difference de-
tectable 20 %, standard deviation 0.6, at 95 % power and
5 % significant level, the minimum adjusted sample size
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that 10 % of participants may be lost prior to completing
the 3-months and 6-months follow-up assessments so that
the final sample was 515. To round up, a total of 600 alco-
hol and tobacco misuse patients were eligible and con-
sented to be screened for substance misuse over a period
of six months. Based on the pilot study in February 2014,
found 20 % of target population have moderates risk
for alcohol and tobacco. Thus, this project has to screen
about 3000 patients to reach the sample size.
Data analyses
Means, standard deviations, and percentages were used
for descriptive statistics. Mann–Whitney U Test for
continuous data and chi-square for categorical data were
used to examine baseline differences between groups. We
first inspected all outcome variables for distribution prop-
erties. Variables that were significantly skewed, the total
ASSIST scores were transformed using the formula log10
(χ + 1) with non-transformed observed values presented in
the table. The primary outcome was measured at three
time points: baseline, three and at six months. If a par-
ticipant dropped out, and was not present on the day of
the interview or refused to answer questions the primary
outcome at the end point of the trial was missing. TheAssessed for el
Analysed (n= 157)
3 months follow-up (n=162)
6 months follow-up (n=157)
Lost to follow-up (not found/reached) (n=58)
Allocated to intervention (n=215)
Received allocated intervention (n=215)
1 session (215); 2 sessions (185: 86%); 








Fig. 1 Flow-chart of participants in the trialresearchers used an intent-to-treat analysis by including
all participants who completed baseline assessments and
who were randomized to intervention conditions. Listwise
deletion (i.e., using complete cases only) in the context
of generalized estimating equations (GEE) was used with
missing data. The extent of the missing component was
27.4 % at six months. The method used to take account of
the stratified trial design, the repeated binary and linear
nature of the primary outcomes (Risky drinking, Tobacco
use abstinence) and the missing data at follow-up is a GEE
approach [46]. Estimated treatment effects are reported
with 95 % confidence intervals. IBM SPSS for Windows




Figure 1 summarizes patient identification, recruitment,
randomization, and follow-up numbers. We identified 3561
hospital out-patients, of which 2758 did not meet the inclu-
sion criteria, 146 refused to participate, 46 were referred,
resulting in 620 hospital out-patients who screened positive
for both tobacco and alcohol moderate risk agreed to
participate in the trial. Participants in the four hospitals
were randomized into 2 control and 1 interventionigibility (n= 3561)
Excluded  (n=  3414)
Not meeting inclusion criteria (n= 2758) 
Declined to participate (n= 146)
Referred (n= 46)
Other reasons (n= 0 )
3 months follow-up: tobacco (n=148) alcohol (n=152)
6 months follow-up: tobacco (n=143) alcohol (n=150)
Lost to follow-up (not found/reached) (n= 112)
llocated to control 1: Tobacco (n= 199)
Received 1 session (n= 199) (2=147: 74%, 3=147: 74%) 
llocated to control 2: Alcohol (n= 206)
Received 1 (n= 206) (2 sessions=180: 87%; 3=175: 85%) 
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(2 intervention and 2 control hospitals) to 405 patients
in the two control groups (tobacco only intervention,
n = 199, and alcohol only intervention, n = 206) and 215
in the intervention group. The intervention consisted
of three counselling sessions. In the integrated alcohol
and tobacco intervention group 86 % attended two and
82 % three counselling sessions, in the tobacco control
group 74 % attended two and three counselling sessions,
and the alcohol control group 87 % attended two and 85 %
all three counselling sessions. As illustrated in Fig. 1, at the
3-month follow-up, response rates for the intervention andTable 1 Baseline characteristics stratified by study condition (N = 62
Intervention (Tobacco plus alcoh
(n = 215)
N (%) or M (SD)
Sociodemographic variables
Gender (N, % male) 210 (99.7)
Age in years (M, SD) (range 18–60 years) 33.4 (10.8)
Education




Never married 60 (28.0)
Married or cohabiting 140 (65.4)
Separated/Divorced/Widowed 14 (6.5)
Religious affiliation: Buddhist (vs. others) 213 (99.1)
Employed (vs. unemployed or other) 205 (95.8)
Monthly income
<10000 Baht 67 (31.3)
10000-15000 Baht 84 (39.3)
>15000 Baht 63 (29.4)
Tobacco and alcohol use
Tobacco use (ASSIST score) (M,SD) 19.2 (4.4)
Alcohol use (ASSIST score) (M,SD) 16.9 (4.6)
Past week tobacco use (units) 78 (52)
Past week alcohol use (units) 22 (27)





Diazepam or sleeping pills 2 (0.9)
Hallucinogens 0
Opium 0
Other addictive substances 1 (0.5)
M Mean; SD Standard Deviation; df degree of freedom; χ2 Chi-squaretwo control groups were 75.3 %, 74.4 % and 73.8 %, re-
spectively, and at 6 months, the intervention and two con-
trol groups response rates were 73.0 %, 71.9 % and 72.8 %,
respectively. In the intervention group 30.2 % did not
complete the last follow-up survey (i.e., the dropout rate
was 30 %); in the two control groups, 28.1 % and 27.2 %,
respectively, did not complete the last follow-up survey.
Attrition analyses were conducted to check for differen-
tial attrition by examining the condition by dropout inter-
actions at baseline. The odds of completing follow-ups
were not related to treatment condition. Dropout was






N (%) or M (SD) N (%) or M (SD) χ2 or F or t
191 (96.0) 205 (99.5) 5.74; df = 2 0.056
30.7 (10.9) 36.8 (11.0) 15.74; df = 2 <0.001
108 (54.8) 111 (53.9) 2.56; df = 4 0.690
77 (39.1) 80 (38.8)
12 (6.1) 15 (7.3)
46 (23.4) 48 (23.3) 6.47; df = 4 0.126
146 (74.1) 150 (72.8)
5 (2.5) 8 (3.9)
196 (98.5) 205 (99.5) 2.17; df = 2 0.711
176 (89.3) 196 (95.6) 9.16; df = 2 0.011
58 (29.4) 45 (22.0) 6.78; df = 4 0.164
71 (36.0) 93 (45.4)
68 (34.6) 67 (32.7)
21.9 (3.6) 19.3 (4.4) 27.77; df = 2 <0.001
16.2 (4.3) 17.2 (3.9) 2.86; df = 2 0.050
66 (49) 70 (48) 3.58; df = 2 0.032
19 (22) 21 (22) 1.03; df = 2 0.350








Pengpid et al. Substance Abuse Treatment, Prevention, and Policy  (2015) 10:22 Page 7 of 10df = 620; P = 0.027), indicating a relationship between this
variable and dropout status depending on the ASSIST alco-
hol score: 16.1 in the dropout group versus 17.0 in the
group that stayed on in the trial. Dropout was not related
to condition (χ2 = 0.14, df = 3; P = 0.933), age (t = −0.48,
df = 618; P = 0.632), sex (χ2 = 1.76, df = 1; P = 0.185), edu-
cation (χ2 = 2.16, df = 2; P = 0.340), marital status (χ2 =
1.43, df = 2; P = 0.490), employment status (χ2 = 0.92,
df = 1; P = 0.338), religion (χ2 = 1.18, df = 1; P = 0.553),
ASSIST tobacco score (t = −0.41, df = 620; P = 0.685),
tobacco units a week (t = 0.50, df = 620; P = 0.617), and
alcohol units a week (t = 0.06, df = 620; P = 0.955).
Participant characteristics
Table 1. summarizes sociodemographic and substance
use characteristics of the study participants. Overall, the
study sample was 97.7 % male, on average 33.6 (SD = 11.1)
years of age, 53.5 % had primary or less education, 70.4 %
were married or cohabiting, 99 % were Buddhist, 93.6 %
were employed, and 67.6 % had 15000 or less Thai Baht
monthly income.
With regard to substance use variables, the overall
mean ASSIST score was for tobacco use 20.1 (SD = 4.3)
and for alcohol use 16.8 (SD = 4.3). Using the Timeline
Followback (TLFB) interview the mean number of tobacco
use units (cigarettes) was 71.7 (SD = 50.5) in the past 7 days
and 21.0 (SD = 24.6) alcohol standard drinks in the past
7 days. Less than 1 % of the participants reported the
use of other substances, other than alcohol and tobacco
(see Table 1.). In terms of health care seeking behaviourTable 2 Health care seeking for tobacco and or alcohol use and toba
Intervention (Tobacco plus
(n = 215)
N (%) or M (SD)
In the past three months did you consult for your tobacco use any health ca
Health facility 4 (1.9)
Traditional/Complementary medicine provider 2 (0.9)
Self-help or quit line 8 (3.8)
Other provider 2 (1.0)
In the past three months did you consult for your alcohol use any health car
Health facility 0
Traditional/Complementary medicine provider 1 (0.5)
Self-help or quit line 0
Other provider 2 (1.0)
Tendency of smoking more when drinking
Never 33 (15.5)
Sometimes 10 (4.7)
Half of the time 5 (2.3)
Most of the time 58 (27.2)
Every time 107 (50.2)for tobacco use problems in the past 3 months, 1.1 %
had consulted a health facility, 0.3 % a traditional or
complementary medicine provider, 2.6 % self-help or quit
line, and 1 % other providers. Regarding health care seeking
behaviour for alcohol use problems in the past 3 months,
0.2 % had consulted a traditional or complementary medi-
cine provider and 0.7 % other providers. Almost two-thirds
of participants (65.8 %) indicated that most of the time or
every time they would smoke (or use tobacco products)
more whenever they are engaged in drinking alcohol (see
Table 2).Main treatment effects
Results of the interaction (Group × Time) effects using
GEE indicated that there were statistically significant
differences between the three study groups over the 6-
month follow-up on the ASSIST tobacco score (Wald
χ2 = 8.43, P = 0.004), and past week tobacco use abstin-
ence (Wald χ2 = 7.34, P = 0.007). Although there were
no significant interaction effects on the other outcomes
(Alcohol ASSIST score, low alcohol risk score, past week
tobacco abstinence or low alcohol risk score, and past
week tobacco abstinence and low alcohol risk score), the
scores in all of the six outcome measures showed consist-
ent improvements (see Table 3).
For past week tobacco abstinence the tobacco only inter-
vention was more effective than the alcohol only interven-
tion and the integrated alcohol and tobacco intervention






N (%) or M (SD) N (%) or M (SD) χ2 P-value
re provider
1 (0.5) 2 (1.0) 1.83; df = 2 0.397
0 0 3.83; df = 2 0.146
6 (3.0) 2 (1.0) 3.48; df = 2 0.173





1 (0.5) 1 (0.5)
34 (17.3) 43 (21.0) 192.36; <0.001
17 (8.7) 37 (18.0) df = 10
8 (4.1) 23 (11.2)
15 (7.7) 95 (46.3)
122 (62.2) 7 (3.4)
Table 3 Alcohol and tobacco -related outcome measures at baseline, 3-month and 6-month follow-up
Intervention Control Control GEE (Time) GEE (Group x Time)












Past week tobacco use units (M, SD) Baseline (n = 620) 78 (52) 66 (49) 70 (48) 332.38 <0.001 2.60 0.107
3 months (n = 462) 41 (38) 22 (32) 36 (37)
6 months (n = 450) 40 (35) 20 (29) 37 (42)
Past week alcoholic use units (M, SD) Baseline (n = 620) 22 (27) 19 (22) 21 (22) 206.48 <0.001 3.01 0.083
3 months (n = 462) 8 (15) 5 (7) 7 (12)
6 months (n = 450) 12 (18) 5 (9) 6 (10)
Tobacco ASSIST total (M, SD) Baseline (n = 620) 19.2 (4.4) 21.9 (3.6) 19.3 (4.4) 485.08 <0.001 8.43 0.004
3 months (n = 462) 7.0 (4.9) 9.1 (9.1) 8.9 (6.7)
6 months (n = 450) 6.3 (3.9) 9.1 (9.4) 8.5 (6.5)
Past week tobacco abstinent (N, %) Baseline (n = 620) 0 (0.0) 0 (0.0) 0 (0.0) 2000.16 <0.001 7.34 0.007
3 months (n = 462) 31 (19.1) 61 (41.2) 37 (24.3)
6 months (n = 450) 28 (17.7) 70 (49.0) 40 (26.7)
Alcohol ASSIST total (M, SD) Baseline (n = 620) 16.9 (4.6) 16.2 (4.3) 17.2 (3.9) 1810.97 <0.001 1.80 0.179
3 months (n = 462) 5.6 (5.6) 7.5 (7.4) 6.3 (6.3)
6 months (n = 450) 6.1 (4.9) 8.6 (8.0) 4.8 (5.7)
Alcohol ASSIST score (<11) (N,%) Baseline (n = 620) 0 (0.0) 0 (0.0) 0 (0.0) 486.58 <0.001 1.07 0.301
3 months (n = 462) 131 (80.9) 96 (64.9) 110 (72.4)
6 months (n = 450) 127 (80.9) 86 (60.1) 123 (82.0)
Past week tobacco abstinent OR
Alcohol ASSIST (<11) (N,%)
Baseline (n = 620) 0 (0.0) 0 (0.0) 0 (0.0) 745.64 <0.001 1.05 0.305
3 months (n = 462) 102 (63.0) 63 (42.6) 87 (57.6)
6 months (n = 450) 101 (64.3) 54 (37.8) 91 (60.7)
Past week tobacco abstinent AND
Alcohol ASSIST (<11) (N,%)
Baseline (n = 620) 0 (0.0) 0 (0.0) 0 (0.0) 737.40 <0.001 0.88 0.348
3 months (n = 462) 30 (18.5) 47 (31.8) 30 (19.6)
6 months (n = 450) 27 (17.2) 51 (35.7) 36 (24.0)
Pengpid et al. Substance Abuse Treatment, Prevention, and Policy  (2015) 10:22 Page 8 of 10Discussion
To our knowledge, this is the first randomized trial to
evaluate the efficacy of a concurrent brief intervention
of conjoint moderate risk of alcohol and tobacco use,
compared to the single intervention of either smoking
cessation or alcohol risk reduction of conjoint alcohol
and tobacco users, in hospital out-patients in Thailand.
The trial was conducted in 4 district hospitals, with out-
patients in two hospitals serving as intervention group,
the third hospital with the single tobacco use cessation
serving as control group one and the fourth hospitalTable 4 Treatment effect by intervention type
Outcome Group x Time-Intervention
Past week tobacco abstinent Alcohol + Tobacco versus Tob
Alcohol + Tobacco versus Alco
Tobacco only versus Alcohol
B Beta Coefficient; CI Confidence Intervalwith the single alcohol intervention serving as control
group two. Self-reported outcome data suggest that the
all three intervention approaches, the provision conjoint
alcohol and tobacco intervention and the single tobacco
or alcohol control intervention were all effective in redu-
cing levels of moderate risk of alcohol and or tobacco use
in hospital out-patients. From baseline to 3- and 6-month
follow-up, both alcohol consumption and tobacco use
declined significantly in both intervention (conjoint
intervention) and control groups (single intervention).
Contrary to a previous review [47], this study found aB (CI 95 %) P-value
acco only −1.34 (−1.74, −0.94) <0.001
hol only −0.50 (−0.94, −0.06) 0.028
only 0.84 (0.47, 1.21) <0.001
Pengpid et al. Substance Abuse Treatment, Prevention, and Policy  (2015) 10:22 Page 9 of 10significant reduction of tobacco use in the alcohol use
intervention control group, meaning that a brief alco-
hol intervention also reduced cigarette smoking. It is
possible that there is a spill over effect when tackling
one risk behaviour it could also reduce another risk
behaviour.
The alcohol outcomes were reasonably good, and com-
parable to those reported in previous studies with hospital
patients [48, 49], and the self-reported past 7 days tobacco
use abstinence was also good (with the lowest, 17.7 %, in
the integrated intervention and the highest, 49.0 %, in the
single tobacco use intervention), compared to previous
studies [50, 51].
Results of the interaction (Group × Time) effects using
GEE indicated that there were statistically significant
differences between the three study groups over the
6-month follow-up on the ASSIST tobacco score and
past week tobacco use abstinence. We would have expected
that participants receiving the integrated or concurrent al-
cohol and tobacco use intervention were significantly more
likely to be abstinent from tobacco use than those receiving
a tobacco use only intervention, as found in a previous
study [17]. However, this study found that the tobacco use
only intervention was more effective in achieving tobacco
use abstinence than the integrated or concurrent alcohol
and tobacco intervention. This finding is unclear and needs
further investigation.Study limitations
Our study has several limitations, including the loss of
patients at each follow-up point.
Further, alcohol and tobacco use was only assessed by
self-report and should be verified by biomedical mea-
sures in future studies [17]. Moreover, the study only
assessed short-term intervention effects (6 months) and
longer term assessments (12 months) would be needed
to assess the sustainability of intervention effects. More-
over, the study included volunteering out-patients from
only one or two district hospitals per intervention arm,
and thus not meaningful clusters could be formed for
randomization and analysis. Further, the study found
a large proportion (27 %) were lost to follow up at
6 months, while in the estimation of the sample size
the lost to follow-up was set at 10 %, thus, the dataset
obtained is incomplete and may not be representative
of the groups. Moreover, dropout was associated with
a low ASSIST alcohol score. Since the first ASSIST
measurements were disclosed to the groups those not
considering themselves at higher risk were less moti-
vated to continue in the study. Another study limita-
tion included that only a single blind method of the
observers has been included in the methodology, while
a double or triple blind is preferred. This being so, mayhave influenced results especially in control groups receiv-
ing only alcohol or only tobacco counselling.
Conclusion
The study found that for past week tobacco abstinence
the tobacco only intervention was more effective than the
alcohol only intervention and the polydrug use (alcohol
and tobacco) integrated intervention. Further, research is
needed to show if a polydrug use (alcohol and tobacco) in-
tegrated intervention can be more effective than a single
drug use intervention. The ASSIST brief intervention
recommend, “While feedback would be given on all sub-
stances scoring in the moderate or high risk range, the
focus of the intervention should be directed toward the
substance(s) that are creating the most problems for
the client or is of most concern to the client.”([38], p.26)
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